Illumina Quick ratio
Was ist das Quick ratio von Illumina?
Quick ratio von Illumina, Inc. ist 0.72
Was ist die Definition von Quick ratio?
Einzugsliquidität (Quick Ratio) ist die Liquiditätsquote, die die Fähigkeit eines Unternehmens misst, seine kurzfristigen Vermögenswerte zur sofortigen Erfüllung seiner kurzfristigen Verpflichtungen einzusetzen.
The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.
Quick ratio von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu Illumina
Was macht Illumina?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Unternehmen mit quick ratio ähnlich Illumina
- Unex hat Quick ratio von 0.72
- NewOcean hat Quick ratio von 0.72
- Indoco Remedies hat Quick ratio von 0.72
- Baoye hat Quick ratio von 0.72
- Garrett Motion Inc hat Quick ratio von 0.72
- Novartis AG hat Quick ratio von 0.72
- Illumina hat Quick ratio von 0.72
- Exelon hat Quick ratio von 0.72
- Exelon hat Quick ratio von 0.72
- Haier Smart Home Co hat Quick ratio von 0.72
- Goodbaby International hat Quick ratio von 0.72
- Apar Industries hat Quick ratio von 0.72
- Kontoor Brands hat Quick ratio von 0.72